Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
PTC Therapeutics Inc
Nieuws
PTC Therapeutics Inc
PTCT
NAS
: PTCT
| ISIN: US69366J2006
3/05/2024
33,01 USD
(-1,81%)
(-1,81%)
3/05/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
2 mei 2024 ·
PTC Therapeutics to Participate at Upcoming Investor Conferences
· Persbericht
25 april 2024 ·
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
· Persbericht
23 april 2024 ·
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
· Persbericht
11 april 2024 ·
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
· Persbericht
28 maart 2024 ·
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
· Persbericht
19 maart 2024 ·
PTC Therapeutics Provides Key Regulatory Updates
· Persbericht
29 februari 2024 ·
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
27 februari 2024 ·
PTC Therapeutics to Participate at Upcoming Investor Conferences
· Persbericht
22 februari 2024 ·
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
· Persbericht
15 februari 2024 ·
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
25 januari 2024 ·
CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure
· Persbericht
8 januari 2024 ·
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference
· Persbericht
3 januari 2024 ·
PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference
· Persbericht
14 december 2023 ·
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
· Persbericht
5 december 2023 ·
PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities
· Persbericht
3 november 2023 ·
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
· Persbericht
27 oktober 2023 ·
Thinking about buying stock in Rivian Automotive, Heritage Global, Enphase Energy, PTC Therapeutics, or Hanryu Holdings?
· Persbericht
26 oktober 2023 ·
PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results
· Persbericht
19 oktober 2023 ·
PTC Therapeutics Announces Evrysdi® Royalty Agreement with Royalty Pharma for Up To $1.5 Billion
· Persbericht
16 oktober 2023 ·
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2023 Financial Results
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe